Article
[Prognostic and predictive molecular markers for urologic cancers].
Der Urologe. Ausg. A - 1 Apr 2014
Hartmann A, Schlomm T, Bertz S, Heinzelmann J, Hölters S, Simon R, Stoehr R, Junker K
Abstract excerpt
Molecular prognostic factors and genetic alterations as predictive markers for cancer-specific targeted therapies are used today in the clinic for many malignancies. In recent years, many molecular markers for urogenital cancers have also been identified. However, these markers are not clinically used yet. In prostate cancer, novel next-generation sequencing methods revealed a detailed picture of the molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
